Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Nature Communications|February 8, 2024
Targeting DNA2 overcomes metabolic reprogramming in multiple myelomaNatthakan Thongon, Feiyang Ma, Natalia Baran, et al.
Leukemia|August 26, 2023
Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targetsMinako Mori, Yasuo Kubota, Arda Durmaz, et al.
Blood Advances|October 3, 2018
KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in miceYue Wei, Hong Zheng, Naran Bao, et al.
Leukemia|August 6, 2020
Complex landscape of alternative splicing in myeloid neoplasmsCourtney E Hershberger, Devlin C Moyer, Vera Adema, et al.
Experimental Hematology|December 8, 2009
Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone diseaseKatia Todoerti, Gina Lisignoli, Paola Storti, et al.
Blood Advances|July 20, 2019
Distinct clinical and biological implications of CUX1 in myeloid neoplasmsMai Aly, Zubaidah M Ramdzan, Yasunobu Nagata, et al.
Nature Communications|April 11, 2025
Natural killer cells' functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromesJuan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Bijender Kumar, et al.
Leukemia|June 13, 2022
Cooperation between KDM6B overexpression and TET2 deficiency in the pathogenesis of chronic myelomonocytic leukemiaYue Wei, Rashmi Kanagal-Shamanna, Hong Zheng, et al.
Cell Reports. Medicine|February 1, 2025
An integrative multiparametric approach stratifies putative distinct phenotypes of blast phase chronic myelomonocytic leukemiaKristian Gurashi, Yu-Hung Wang, Fabio M R Amaral, et al.
Iscience|March 17, 2023
A multimodal analysis of genomic and RNA splicing features in myeloid malignanciesArda Durmaz, Carmelo Gurnari, Courtney E Hershberger, et al.
Pageof 10